epilepsy-associated conditions, it can be difficult to determine the pathogenicity of variants in genes found using an exome-wide testing method. Therefore, identifying a more detailed phenotype associated with a particular gene allows for better interpretation of sequencing results and more confidence in predictions of pathogenicity.
Overlapping chromosomal microdeletions can be useful in the initial identification of phenotypes associated with haploinsufficiency of a particular gene. Patients with 1q44 deletions have previously been described with a phenotype of developmental delay (particularly speech), microcephaly, hypogenesis/agenesis of the corpus callosum and seizures. Analysis of the smallest region of overlap has identified the HNRNPU (Heterogeneous Nuclear Ribonucleoprotein U) gene as a candidate for the epilepsy and intellectual disability (ID) phenotype associated with this microdeletion (Caliebe et al., 2010; Thierry et al., 2012) .
HNRNPU loss-of-function mutations have been associated with epilepsy and developmental delay in individual patients as part of larger cohorts (Carvill et al., 2013; de Kovel et al., 2016; Epi4K-Consortium, 2013; Hamdan et al., 2014; Need et al., 2012) . Recently, two series confirming the association of HNRNPU mutations with epilepsy and ID have been published (Bramswig et al., 2017; Depienne et al., 2017) . However, the phenotypic spectrum still remains to be delineated. In particular, a common dysmorphic phenotype has not yet been fully defined.
Here, we report seven patients with de novo mutations in HNRNPU. Six of these patients were identified through the Wellcome Trust Deciphering Developmental Disorders (DDD) study (Wright et al., 2015) with an additional patient identified via MatchMaker exchange (Philippakis et al., 2015) . We demonstrate common phenotypic features, including facial dysmorphism, ID, seizures, and behavioral problems. This previously-undescribed pattern of features allows us to define a novel neurodevelopmental syndrome.
| MATERIALS AND METHODS
Patients 1 to 6 were identified through the DDD study. Recruitment to this study was via UK regional Clinical Genetics centres after routine referral. The affected person and their parents underwent trio-based exome sequencing and analysis as previously published (Wright et al,. 2015) . Array-based comparative genomic hybridiza- Patient 1 is a female, born to non-consanguineous parents. The family history was unremarkable. The pregnancy was complicated by gestational diabetes. She was born at 38 weeks gestation by emergency caesarean section. Her birth-weight was on the 75th centile. She walked independently after the age of 2 years. Her first words were at the age of 5 years.
On assessment at the age of 15 years, her head circumference was on the 75th centile, weight between the 98th and 99.6th centile and height between the 9th and 25th centiles.
She had special educational needs and moderate ID. She developed epilepsy at the age of approximately 1 year. Her seizures were frequent, primarily absences, and could be triggered by fevers.
Dysmorphic features included a short philtrum, thin upper lip, deep-set eyes, and long eyelashes. Her gait was wide-based and she was noted to have hand-flapping movements. Magnetic resonance imaging (MRI) of the brain and echocardiogram were normal.
| Patient 2 (DECIPHER ID: 260453)
Patient 2 is a male, born to non-consanguineous parents. He was noted to have two maternal uncles with mild learning difficulties and a maternal cousin with autism. During pregnancy, cardiac abnormalities were found on the 20 week antenatal ultrasound. He was born at 37 weeks gestation. Birth-weight was between the 2nd and 9th centiles. He was found to have transposition of the great vessels, tricuspid atresia, and a ventricular septal defect. He had pulmonary artery banding on the first day of life and has subsequently undergone multiple cardiac operations. He walked independently, and spoke his first words after the age of 2 years.
He had special educational needs, and has moderate ID. He was noted to be emotionally labile and to anger easily. He did not have any seizures or hand-flapping movements. He also developed a brain abscess at the age of 8 years and had recurrent ear infections. He has been diagnosed with Tourette syndrome.
On assessment at the age of 14 years, his head circumference was between the 2nd to 9th centiles, weight between 9th and 25th centiles and height between the 2nd to 9th centiles. His facial features were thought to resemble his family. He had a left single transverse palmar crease.
He is now attending an adult education college. He has learning difficulties, particularly regarding communication and social skills. He uses a wheelchair and scooter for mobility. He cannot walk or propel his wheelchair for long distances. MRI brain as a child demonstrated small periventricular areas with high T2 signal, thought to be non-specific, but possibly due to previous ischaemic events. He was additionally found to have maternal uniparental disomy (UPD) of chromosome nine (previously published by King et al., 2014) . It is not certain whether this is significantly contributing to his phenotype.
| Patient 3 (DECIPHER ID: 265865)
Patient 3 is a female, born to non-consanguineous parents. She had a paternal cousin with development delay and seizures. The pregnancy was complicated by a maternal renal infection. She was born at term, with a birth-weight between the 9th and 25th centiles.
She walked independently after the age of 4 years and her first words were at the age of 18 months. She was able to speak a few words by the age of 3 years. She was also noted to be hypotonic as an infant.
She was thought to have autistic traits. She had special educational needs and severe ID. She developed epilepsy at the age of one year, initially febrile seizures, which have now resolved.
On assessment, at the age of 12 years, her height was on the 9th centile and weight on the 96th centile. Her head circumference was previously on the 25th centile at the age of three-and-a-half years.
She had dysmorphic features including synophrys with thick eyebrows and a short nose. She had hand flapping when excited.
Her echocardiogram was normal.
| Patient 4 (DECIPHER ID: 268390)
Patient 4 is a female, born to non-consanguineous parents. The family history was unremarkable. The pregnancy was uncomplicated.
She was born at 38 weeks gestation, with a birth-weight on the 2nd centile.
She crawled at 2 years 9 months of age, and walked independently at the age of approximately 5 years. Her first words were at around four-and-a-half years of age, and she had limited communication with
Makaton sign language prior to this.
Drooling has been a long-standing problem. Initially this was treated with hyoscine patches, but she later required bilateral transtympanic neuronectomy. This gave a good result initially, but drooling has started to worsen again. She has also previously had conductive hearing loss with vent insertion. She had a single seizure at the age of approximately 5 years. She had special educational needs. She displayed good comprehension, but her words remained unclear and speech was limited to short sentences.
On assessment at the age of six-and-a-half years, her head circumference was on the 0.4th centile, weight between the 25th and 50th centiles, and height between the 0.4th and 2nd centiles.
She had dysmorphic features including: low-set, posteriorly rotated ears, strabismus, anteverted nares, a prominent metopic ridge, epicanthic folds, smooth philtrum, thin vermillion border, and twothree toe cutaneous syndactyly bilaterally ( Figure 3 ). She is hypermobile, particularly affecting the upper limbs. She had hand-flapping behaviors, and a generally pleasant demeanour. She was also myopic. MRI brain scan was normal at 2 years of age.
| Patient 5 (DECIPHER ID: 277603)
Patient 5 is a female, born to non-consanguineous parents. The family history was unremarkable. The pregnancy was uncomplicated. She was born at term, with a birth-weight between the 50th and 75th centiles.
She walked independently at around 2 years of age. Her first words were after 2 years. 1 (258995) 2 (260453) 3 (265865) 4 (268390) 5 (277603) 6 ( n/a n/a n/a n/a n/a 1 (258995) 2 (260453) 3 (265865) 4 (268390) 5 (277603) 6 ( 
| Patient 6 (DECIPHER ID: 263453)
Patient 6 is a female, born to non-consanguineous parents. The family history was unremarkable. The pregnancy was uncomplicated. She was born at 42 weeks gestation, with a birth-weight on the 9th centile. Her parents had concerns about her development from 4 months of age, as she had hypotonia and delayed milestones.
She did not walk independently until the age of 3 years. Her speech was delayed, particularly expressive. At age 11 years, she still had no formal words, but could communicate through signing and using a picture board on a computer pad. She has special educational needs, and attends a school for children with severe ID. She has a sociable, loving personality. She has repetitive mannerisms, such as hand-flapping movements, particularly when excited.
She developed epilepsy with generalized tonic-clonic seizures at the age of 8 months. These were well-controlled on sodium valproate. Her seizures resolved and she was weaned off treatment aged 6 years.
On assessment at the age of 11 years, her head circumference was on the 75th centile, weight on the 75th centile, and height on the 2nd centile. Dysmorphic features included thick hair and eyebrows, prognathism, broad thumbs and great toes, and truncal obesity. She walked with a wide-based, unsteady gait, with hypermobility, especially at her ankles, requiring supportive footwear. MRI brain at the age of 1 year demonstrated delayed myelination, but no other abnormalities.
| Patient 7
Patient 7 is a female, born to non-consanguineous parents. The family history was unremarkable. The mother had ovarian stimulation prior to pregnancy. This patient is one of a dizygous twin pair; the other twin is unaffected. The pregnancy was uncomplicated. This patient was born at 38 weeks gestation with a birth-weight on the 0.4th centile. She was admitted to the Special Care Baby Unit due to complications related to low birthweight. She sat independently at 18 months of age, and walked independently at six-and-a-half years. Her first words were at 3 years of age.
On assessment at the age of eight-and-a-half years, her head circumference was on the 2nd to 9th centile, weight on the 2nd centile, and height below the 0.4th centile. She did not have any dysmorphic features. She had moderate ID. She developed generalized seizures at the age of 18-months, which were initially triggered by fevers. She was treated with Levetiracetam. Her seizures resolved and she was weaned off treatment aged 5 years. Hand flapping 5/7 1/7 1/6 n/r n/r n/r n/r 7/20 (35%)
Abnormal MRI-brain 2/7 3/5 4/4 1/1 1/1 n/r n/r 11/18 (61%)
Note the patient previously reported by Hamdan et al. (2014) has been described in more detail by Bramswig et al. (2017) . ID, intellectual disability; n/a, not applicable; n/r, not reported, PF; palpebral fissures.
MRI brain scans at the ages of 3 and 7 years showed nonprogressive T2 and FLAIR hyperintense lesions involving the deep white matter bilaterally, with sparing of the occipital lobes and basal ganglia.
| Sequencing results
Each patient was found to have a heterozygous de novo mutation in HNRNPU (Table 1 ; Figure 1 ). Patient 2 was also previously noted to have complete maternal UPD of chromosome nine (King et al., 2014) .
HNRNPU is an RNA-binding protein, expressed in brain (particularly the cerebellum), heart, kidney, and liver (Thierry et al., 2012) . It is largely localized to the nucleus, functioning as a mediator of alternative splicing and in transcriptional regulation (Geuens, Bouhy, & Timmerman, 2016) . Reduced expression of Hnrnpu results in embryonic lethality in mice (Roshon & Ruley, 2005) . Hnrnpu cardiac-specific knockout results in a rapidly progressive dilated cardiomyopathy, with widespread dysregulation of splicing (Ye et al., 2015) .
The role of HNRNPU in transcriptional regulation can be mediated through an interaction with long noncoding RNA (lncRNA), which are increasingly recognized as playing a role in gene expression (Lin et al, 2017) . For example, HNRNPU plays a crucial role in X-inactivation, by enabling chromosomal localisation of the lncRNA Xist, as well as being required for Xist-mediated function (Hasegawa et al., 2010) .
Hnrnpu has also been shown, in mice, to give rise to circular RNA (ciRNA), with expression almost entirely in neurons. ciRNA have an emerging role in a number of areas including regulation of microRNA function and alternative splicing (Reddy et al., 2017) . HNRNPU is part of a larger family of hnRNP (Heterogeneous Nuclear Ribonucleoproteins). Interestingly, other hnRNP have been implicated in neurological disease and cancer (Geuens et al., 2016) , emphasising the wide-ranging functions of these proteins.
| HNRNPU-related syndrome
The patient series presented here clarifies and delineates the phenotypic features associated with HNRNPU mutations (Tables 2   and 3 One patient in our series (Patient 2) was also found to have maternal UPD of chromosome nine (King et al., 2014) . No other variants were identified. To the authors' knowledge, there is no definite evidence of imprinting on this chromosome, and UPD 9 (mat) has been reported in a phenotypically normal individual (Bjorck, Anderlid, & Blennow, 1999 (Caliebe et al., 2010; Thierry et al., 2012) . More recently, this has been confirmed in a series directly comparing the phenotypes of patients with 1q43q44
microdeletions to those with loss-of-function HNRNPU mutations (Depienne et al., 2017) . This study showed that changes in HNRNPU determine the epilepsy phenotype in 1q43q44 syndrome, and have a significant influence on the degree of ID.
A recent series of six individuals with HNRNPU mutations also demonstrates an ID and epilepsy phenotype (Bramswig et al., 2017) .
Interestingly, all of these patients have severe ID, in contrast to our cohort, in which 4/7 patients have moderate learning difficulties. Therefore, the significance of these mutations, and the possible clustering in B30.2/SPRY, remains to be defined.
In addition, 4/6 individuals in the study of Bramswig et al. (2017) had cardiac abnormalities and 3/4 renal abnormalities. Only one of our patients had cardiac abnormalities, and, as discussed, this may be associated with his UPD of chromosome 9. None of our patients had renal problems. Our findings therefore do not support the association of HNRNPU mutations with cardiac and/or renal abnormalities.
| CONCLUSION
In summary, we present evidence that a neurodevelopmental syndrome with features including ID, seizures, behavioral abnormalities, and craniofacial dysmorphism, is associated with de novo loss of function mutations in HNRNPU. This delineation of the phenotype should aid identification of further clinically affected patients and allow for more accurate interpretation of results obtained through genomic testing.
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